AGA Family of Websites:

Announcing new COVID vaccines and IBD program starting Feb. 16

Learn how to develop strategies and address questions related to the use of COVID vaccines on IBD patients using immunomodulator and biologic medications.
COVID Vaccines and IBD Asset Package_GASTRO.ORG _BANNER_1920x1080
COVID Vaccines and IBD Asset Package_GASTRO.ORG _BANNER_1920x1080

Register for and attend the 30-minute live webinar, COVID Vaccines and IBD: Answering your Patients’ Questions (and Yours), taking place virtually on Feb. 16, at 1 p.m. EST.

The live webinar and its eight to 10 accompanying on-demand modules (each 10-15 minutes long) were developed by AGA in partnership with the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) to help practitioners craft strategies for patient communication and COVID vaccine adherence.

The live webinar will cover IOIBD consensus statements and recent Canadian Association of Gastroenterology guidelines. The modules will focus on case-based scenarios covering a variety of medical, geographic, cultural and community concerns about IBD patients and the vaccines.

The live webinar is taught by esteemed IBD experts:

  • Maria Abreu, MD, AGAF, Director, Crohn’s & Colitis Center, University of Miami
  • Iris Dotan, MD, Director of the Division of Gastroenterology, Rabin Medical Center Israel
  • Gil Y. Melmed, MD, MS, AGAF, Director of Clinical Research and Advanced IBD Training, Co-Director of Clinical Operations Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center

To learn more and register, visit AGA University.  

Your hub for GI education is
AGA University

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.